Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Dan5tanton
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Dan5tanton
-
Breaking: Catalent
$CTLT to buy Orgenesis'#celltherapy#CDMO biz Masthercell for $315m - story@BioProInsider Insider https://buff.ly/36PRRod pic.twitter.com/gdXg2Jb6nZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Oklahoma has introduced a bill intended to ban the state from prescribing, administering, and making medicinal products and vaccines containing human DNAhttps://lnkd.in/dXqB-23
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
VGXI will make Inovio Pharmaceuticals’ investigational
#vaccine as part of a collaborative effort to halt the progress of the#coronavirus that has recently emerged in Chinahttps://lnkd.in/dXMHxsMHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lack of good
#CDMOs a factor for@KrystalBiotech in investing $70-90m into internal PA gene therapy plant https://buff.ly/2Obgc1e pic.twitter.com/wqhhN650eL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ori: Partnerships key to bring down cell therapy COGS - UK firm says its automated closed manufacturing platform can reduce autologous
#celltherapy COGS by 60-80% and has teamed with#CDMO@HCATS_CDMO https://buff.ly/2RUbKoM pic.twitter.com/S7edQXpzFo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Advanced Therapies Are Reshaping Biopharma R&D: KPMG Report https://xconomy.com/national/2020/01/28/advanced-therapies-are-reshaping-biopharma-rd-kpmg-report/ … via
@xconomyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioIntelliSense Debuts “Sticker” Sensor to Capture Patient Data Remotely https://xconomy.com/boulder-denver/2020/01/28/biointellisense-debuts-sticker-sensor-to-capture-patient-data-remotely/ … via
@xconomyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Top 10 advanced therapy milestones of 2019: Patient access takes center stage https://shar.es/a38DvA
#plw2020Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
It's here! Falcon CEO Susan Nichols’ annual roundup of top events within the cell and gene therapy space in 2019, from
@Phacilitate#PLW2020 Contains#CRISPR capacity, and#BigPharma M&A , but#patientaccess takes the top spot https://buff.ly/3aLsBmf pic.twitter.com/yCG1G6X0Wf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Discovery Labs' newly formed CDMO in $1.2bn push to deliver capacity to cell & gene space at ex-GSK site in PA - Bioprocess Insider, from
@Phacilitate#plw2020 https://buff.ly/2ROxPoC pic.twitter.com/WaZg8fJc6z
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dan Stanton proslijedio/la je Tweet
FDA rejection letters typically stay private. Correspondence between the agency and
@Sarepta shed light on the thinking that led to the rejection and subsequent approval of Duchenne muscular dystrophy drug#golodirsen https://xconomy.com/boston/2020/01/22/fda-flags-risk-of-infection-kidney-damage-for-sarepta-duchenne-drugs/ …$SRPTHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
newly formed
#CDMO Center for Breakthrough Medicines from Discovery Labs is building what it claims to be the world’s largest third-party cell and gene production facility at ex-GSK site in King of Prussia, Pennsylvania https://buff.ly/2O9O4MfHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
And here is the full story from
@phacilitate courtesy of@BioProInsider 'CDMO aims ‘big’ in $1.2bn push to deliver capacity to cell & gene space' https://tinyurl.com/Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hey
@airfrance@AirFranceUS - you changed my flight home without giving a reason. Spoke to your partners@Delta (as they awere the US contact on your website) who couldn't explain either but were so helpful and friendly. Maybe you should look to them as a customer service modelHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dan Stanton proslijedio/la je Tweet
The Phacilitate Fun Run crew gearing up for a brisk Miami 4k. A great showing, a great cause, and a great conference! Thanks
@Phacilitate@EWhiteheadFdn@biotechne#gettingchillywithit#PLW2020#WSCS20pic.twitter.com/KgqaeFf80L
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
received a PR claiming creation of world’s largest cell gene
#cdmo . Seemed pie in the sky but talk at#plw2020 by MLP Ventures founder Brian O’Neill behind project was inspirational and 1.6m sqft PA site could turn industry on its head. Ps he got huge cheer from a full roompic.twitter.com/3WHijiPpar
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
FDA cell and gene therapy forecast ‘unlikely’ - the opinion from Phacilitate
#PLW2020 as number of commercialized therapeutics falls flat after dynamic 2017 https://buff.ly/2tFZyzK pic.twitter.com/9G029ZUYEv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hey
@Phacilitate feeling pretty silly that I’ve been using#phacilitate rather than#PLW2020 D’oh!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Mixture of pride of advancement but disappointment in relatively few commercial cell and gene products is the feeling at this year’s
#phacilitate in miami. Article to come on@BioProInsiderHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.